About Vertex Pharmaceuticals
Vertex Pharmaceuticals is a company based in United States founded in 1989 by Joshua Boger.. The company has 6,100 employees as of December 31, 2024. Vertex Pharmaceuticals has completed 4 acquisitions, including Alpine Immune Sciences, Exonics and Semma Therapeutics. Vertex Pharmaceuticals offers products and services including Cystic Fibrosis Medicines, Kidney Disease Treatments, and Clinical Trial Programs. Vertex Pharmaceuticals operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter United States
- Employees 6100 as on 31 Dec, 2024
- Founders Joshua Boger
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vertex Pharmaceuticals Incorporated
-
Annual Revenue
$10.98 B11.64as on Dec 31, 2024
-
Net Profit
$-535.6 M-114.8as on Dec 31, 2024
-
EBITDA
$4.57 B2.39as on Dec 31, 2024
-
Latest Funding Round
$350 K (USD), Grant
Feb 02, 2010
-
Investors
HHS
& 1 more
-
Employee Count
6100
as on Dec 31, 2024
-
Investments & Acquisitions
Alpine Immune Sciences
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Vertex Pharmaceuticals
Vertex Pharmaceuticals is a publicly listed company on the NASDAQ with ticker symbol VRTX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Vertex Pharmaceuticals
Vertex Pharmaceuticals offers a comprehensive portfolio of products and services, including Cystic Fibrosis Medicines, Kidney Disease Treatments, and Clinical Trial Programs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatments targeting cystic fibrosis symptoms and progression
Medicines for APOL1-mediated kidney diseases
Platforms for testing new medicines in trials
Unlock access to complete
Unlock access to complete
Leadership Team
249 people
Software Development Team
218 people
Senior Team
136 people
Principal Team
61 people
Finance and Accounting
53 people
Operations Team
35 people
Legal and Compliance
34 people
Sales and Marketing
30 people
Unlock access to complete
Funding Insights of Vertex Pharmaceuticals
- Total Funding Total Funding
- Total Rounds 7
- Last Round Grant — $350,000
-
First Round
First Round
(10 Nov 1994)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2010 | Amount | Grant - Vertex Pharmaceuticals | Valuation |
investors |
|
| Oct, 2009 | Amount | Post-IPO - Vertex Pharmaceuticals | Valuation |
investors |
|
| May, 2009 | Amount | Grant - Vertex Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Vertex Pharmaceuticals
Vertex Pharmaceuticals has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS and Athyrium Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vertex Pharmaceuticals
Vertex Pharmaceuticals has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Alpine Immune Sciences, Exonics and Semma Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
CRISPR/Cas-9 therapies for Duchenne Muscular Dystrophy are developed.
|
2016 | ||||
|
Developer of immunotherapies to treat cancer and autoimmune disorders
|
2015 | ||||
|
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Vertex Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vertex Pharmaceuticals Comparisons
Competitors of Vertex Pharmaceuticals
Vertex Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vertex Pharmaceuticals
Frequently Asked Questions about Vertex Pharmaceuticals
When was Vertex Pharmaceuticals founded?
Vertex Pharmaceuticals was founded in 1989 and raised its 1st funding round 5 years after it was founded.
Where is Vertex Pharmaceuticals located?
Vertex Pharmaceuticals is headquartered in United States.
Who is the current CEO of Vertex Pharmaceuticals?
Reshma Kewalramani is the current CEO of Vertex Pharmaceuticals.
How many employees does Vertex Pharmaceuticals have?
As of Dec 31, 2024, the latest employee count at Vertex Pharmaceuticals is 6,100.
What is the annual revenue of Vertex Pharmaceuticals?
Annual revenue of Vertex Pharmaceuticals is $10.98B as on Dec 31, 2024.
What does Vertex Pharmaceuticals do?
Vertex Pharmaceuticals was founded in 1989 in the United States. Operations focus on the biotechnology sector, where small molecule drugs are developed to address cystic fibrosis, viral diseases, inflammation, autoimmune conditions, cancer, and pain. Treatments such as IVACAFTOR and LUMACAFTORIVACAFTOR target the CFTR protein by enhancing channel opening and preventing misfolding. In 2022, annual revenues reached 8.93 billion, with net profit at 3.32 billion.
Who are the top competitors of Vertex Pharmaceuticals?
Vertex Pharmaceuticals's top competitors include Merck, Roivant Sciences and AbbVie.
What products or services does Vertex Pharmaceuticals offer?
Vertex Pharmaceuticals offers Cystic Fibrosis Medicines, Kidney Disease Treatments, and Clinical Trial Programs.
Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded on NASDAQ under the ticker symbol VRTX.
How many acquisitions has Vertex Pharmaceuticals made?
Vertex Pharmaceuticals has made 4 acquisitions, including Alpine Immune Sciences, Exonics, and Semma Therapeutics.
Who are Vertex Pharmaceuticals's investors?
Vertex Pharmaceuticals has 2 investors. Key investors include HHS, and Athyrium Capital Management.
What is Vertex Pharmaceuticals's ticker symbol?
The ticker symbol of Vertex Pharmaceuticals is VRTX on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.